MedPath

Esmolol Hydrochloride

These highlights do not include all the information needed to use safely and effectively. See full prescribing information for . Initial U.S. Approval:

Approved
Approval ID

59ba978b-a393-421c-9a67-77e690249d88

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 23, 2023

Manufacturers
FDA

WG Critical Care, LLC

DUNS: 829274633

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Esmolol Hydrochloride in Sodium Chloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code44567-451
Application NumberANDA214172
Product Classification
M
Marketing Category
C73584
G
Generic Name
Esmolol Hydrochloride in Sodium Chloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateAugust 23, 2023
FDA Product Classification

INGREDIENTS (2)

NATURAL LATEX RUBBERInactive
Quantity: 0 1 in 1 mL
Code: 2LQ0UUW8IN
Classification: CNTM
ESMOLOL HYDROCHLORIDEActive
Quantity: 20 mg in 1 mL
Code: V05260LC8D
Classification: ACTIB

Esmolol Hydrochloride in Sodium Chloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code44567-450
Application NumberANDA214172
Product Classification
M
Marketing Category
C73584
G
Generic Name
Esmolol Hydrochloride in Sodium Chloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateAugust 23, 2023
FDA Product Classification

INGREDIENTS (2)

ESMOLOL HYDROCHLORIDEActive
Quantity: 10 mg in 1 mL
Code: V05260LC8D
Classification: ACTIB
NATURAL LATEX RUBBERInactive
Quantity: 0 1 in 1 mL
Code: 2LQ0UUW8IN
Classification: CNTM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Esmolol Hydrochloride - FDA Drug Approval Details